Glucose control in diabetes: the impact of racial differences on monitoring and outcomes
Disclosures The LEADER, SUSTAIN-6, REWIND, PIONEER 6, SELECT, SOUL, STEP-HFpEF (with and without diabetes), and FLOW trials were sponsored by Novo Nordisk
Noom defines a microdose as a dose of medication that is a fraction 25% or less of the typically prescribed maintenance dose
That distinction matters throughout this article, because compounded preparations follow a different oversight path than mass-manufactured drugs
In the UK, these include semaglutide 2.4 mg (Wegovy) and liraglutide 3.0 mg (Saxenda), with access governed by NICE technology appraisals